cetuximab (or panitumumab if α-gal IgE+ or cetuximab reaction)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerNCT07644559VSTMPhase 2Recruiting2027-06Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.